Tango Therapeutics (TNGX) Tax Provisions (2020 - 2026)
Tango Therapeutics (TNGX) recorded quarterly Tax Provisions of $1000.0 in Q1 2026, up 101.04% quarter-over-quarter from -$96000.0 in Q4 2025, and down 97.06% on a YoY basis from $34000.0 in Q1 2025.
Tango Therapeutics (TNGX) Tax Provisions (2020 - 2026) Analysis & Trends
Tango Therapeutics' Tax Provisions history runs 7 years deep, the most recent figure standing at $1000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 97.06% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at -$70000.0 (down 145.75% YoY), while the FY2025 annual figure was $4000.0, down 98.0% from the prior year.
- Tax Provisions was $1000.0 for Q1 2026 at Tango Therapeutics, up from -$96000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $65000.0 in Q2 2024 to a low of -$96000.0 in Q4 2025.
- Historically, Tax Provisions has averaged $23923.1 across 5 years, with a median of $35000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions soared 2033.33% in 2023, then tumbled 118.52% in 2025.
- A 5-year view of Tax Provisions shows it stood at $51000.0 in 2022, then dropped by 7.84% to $47000.0 in 2023, then gained by 14.89% to $54000.0 in 2024, then sank by 277.78% to -$96000.0 in 2025, then surged by 101.04% to $1000.0 in 2026.
- The last three Tax Provisions figures came in at $1000.0 (Q1 2026), -$96000.0 (Q4 2025), and -$10000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tango Therapeutics | 4.05 Bn | 3.67 Bn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | -96,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Dec 31, 2022 | 51,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Dec 31, 2021 | 177,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Mar 31, 2021 | 74,000.00 |
| Dec 31, 2020 | 6,864.00 |